Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis

Clinics

Volumn 68, Issue 7, 2013, Pages 909-914

  Pina Cruellas, Marcela Gran ^a   Trindade Viana, Vilma dos Santos ^a   Levy Neto, Maurício ^a   Carlos de Souza, Fernando Henrique ^a   Shinjo, Samuel Katsuyuki ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Dermatomyositis; Idiopathic inflammatory myopathies; Myositis associated autoantibodies; Myositis specific autoantibodies; Polymyositis

Indexed keywords

AUTOANTIBODY; MI 2 ANTIBODIES; MI-2 ANTIBODIES; RIBONUCLEOPROTEIN; SS A ANTIGEN; SS-A ANTIGEN;

ADULT; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; DERMATOMYOSITIS; FEMALE; HUMAN; IMMUNOLOGY; LUNG DISEASE; MALE; MIDDLE AGED; MUSCLE STRENGTH; MYOSITIS; NONPARAMETRIC TEST; ONSET AGE; STATISTICAL MODEL; TIME;

ADULT; AGE OF ONSET; AUTOANTIBODIES; CROSS-SECTIONAL STUDIES; DERMATOMYOSITIS; FEMALE; HUMANS; LOGISTIC MODELS; LUNG DISEASES; MALE; MIDDLE AGED; MUSCLE STRENGTH; MYOSITIS; RIBONUCLEOPROTEINS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 84881038592     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2013(07)04     Document Type: Article

References (40)

1. Feldman BM, Rider LG, Reed AM, Pachman LM. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet. 2008;371(9631):2201-12, http://dx.doi.org/10.1016/S0140-6736(08)60955-1.
2. Nagaraju K, Plotz PH, Miller FW. Inflammatory muscle disease: etiology and pathogenesis. In Rheumatology Edited by: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH. Elsevier, Toronto, Canada; 2003:1523-35.
3. Targoff IN. Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies. Rheum Dis Clin North Am. 2002;28(4):859-90, viii, http://dx.doi.org/10.1016/S0889-857X(02)00032-7.
4. Greenberg SA. Inflammatory myopathies: evaluation and management. Semin Neurol. 2008;28(2):241-9, http://dx.doi.org/10.1055/s-2008-10622 67.
5. Gunawardena H, Betteridge ZE, McHugh NJ. Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology (Oxford). 2009;48(6):607-12, http://dx.doi.org/10. 1093/rheumatology/kep078.
6. Koenig M, Fritzler MJ, Targoff IN, Troyanov Y, Senécal JL. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res Ther. 2007;9(4):R78, http://dx.doi.org/10.1186/ar2276.
7. O'Hanlon TP, Carrick DM, Targoff IN, Arnett FC, Reveille JD, Carrington M, et al. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A,-B,-Cw,-DRB1, and-DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. 2006;85(2):111-27.
8. Chinoy H, Salway F, Fertig N, Shephard N, Tait BD, Thomson W, et al. UK Adult Onset Myositis Immunogenetic Collaboration (AOMIC). In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype. Arthritis Res Ther. 2006;8(1):R13, http://dx.doi.org/10.1186/ar1862.
9. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore). 1991;70(6):360-74.
10. Hengstman GJ, Brouwer R, Egberts WT, Seelig HP, Jongen PJ, van Venrooij WJ, et al. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies. J Neurol. 2002;249(1):69-75.
11. Selva-O'Callaghan A, Labrador-horrillo M, Solans-Laque R, Simeon-Aznar CP, Mez XM, Vilardell-Tarres's M. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum. 2006;55(5):791-8, http://dx.doi. org/10.1002/art.22237.
12. Guirardello A, Rampudda M, Ekholm L, Bassi N, Tarricone E, Zampieri S, et al. Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. Rheumatology (Oxford). 2010;49(12):2370-4, http://dx.doi.org/10.1093/rheumatology/keq281.
13. Váncsaa A, Gergelyb L, Ponyic A, Lakosb G Némethd J, Szodorayb P, et al. Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: Relevance for clinical classification: Retrospective study of 169 patients. Joint Bone Spine. 2010;77(2):125-30, http://dx.doi.org/10.1016/j.jbspin.2009.08.008.
14. Guirardello A, Zampieri S, Tarricone E, Iaccarino L, Bendo R, Briani C, et al. Clinical implications of autoantibody screening in patients with autoimmune myositis A. Autoimmunity. 2006;39(3):217-21, http://dx. doi.org/10.1080/08916930600622645.
15. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344-7.
16. Hanissian AS, Masi AT, Pitner SE, Cape CC, Medsger TA Jr. Polymyositis and dermatomyositis in children: an epidemiologic and clinical comparative analysis. J Rheumatol. 1982;9(3):390-4.
17. Nishikai M, Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum. 1980;23(8):881-8, http://dx.doi.org/10.1002/ art.1780230802.
18. Mimori T, Imura Y, Nakashima R, Yoshifuji H. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance. Curr Opin Rheumatol. 2007;19(6):523-9, http://dx.doi.org/10.1097/BOR.0b013e3282f01a8c.
19. Betteridge Z, Gunawardena H, North J, Slinn J, McHugh N. Antisynthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia. Rheumatology (Oxford). 2007;46(6):1005-8, http://dx.doi. org/10.1093/rheumatology/kem045.
20. Hirakata M, Suwa A, Nagai S, Kron MA, Trieu EP, Mimori T et al. Anti-KS: identification of autoantibodies to asparaginyl transfer RNA synthetase associated with interstitial lung disease. J Clin Invest. 1993;91(6):2556-64.
21. Targoff IN, Trieu EP, Miller FW. Reaction of anti-OJ autoantibodies with components of the multienzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase. J Clin Invest. 1993;91(6):2556-64, http://dx.doi.org/10.1172/JCI116493.
22. Targoff IN, Trieu EP, Plotz PH, Miller FW. Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease. Arthritis Rheum. 1992;35(7):821-30, http://dx.doi.org/10.1002/art.17803 50718.
23. BunnCC, BernsteinRM, MathewsMB. Autoantibodies against alanyl tRNA synthetase and tRNA Ala coexist and are associated with myositis. J Exp Med. 1986;163(5):1281-91, http://dx.doi.org/10.1084/jem.163.5.1281.
24. Mathews MB, Reichlin M, Hughes GR, Bernstein RM. AntithreonyltRNA synthetase, a second myositis-related autoantibody. J Exp Med. 1984;160(2):420-34, http://dx.doi.org/10.1084/jem.160.2.420.
25. Plotz PH, Targoff I. Myositis associated antigens. Aminoacyl-tRNA synthetases. In: Manual of Biological Markers of Disease. Eds, WJ Van Venrooij, R Maini. The Netherlands: Kluwer Academic Publications; 1994.
26. Hashish L, Tribu EP, Sadanandan P, Targoff IN. Identification of autoantibodies to tyrosyl-tRNA synthetase in dermatomyositis with features consistent with antisynthetase syndrome (abstract). Arthritis Rheum. 2004;50(1):209-15.
27. Kao AH, Lacomis D, Lucas M, Fertig N, Oddis CV. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Arthritis Rheum 2004;50:209-15, http://dx.doi.org/10.1002/art.11484.
28. Reeves WH, Nigam SK, Blobel G. Human autoantibodies reactive with the signal-recognition particle. Proc Natl Acad Sci U S A. 1986;83(24):9507-11, http://dx.doi.org/10.1073/pnas.83.24.9507.
29. Targoff IN, Johnson AE, Miller FW. Antibody to signal recognition particle in polymyositis. Arthritis Rheum. 1990;33(9):1361-70, http://dx. doi.org/10.1002/art.1780330908.
30. Wang HB, Zhang Y. Mi-2, an auto-antigen for dermatomyositis, is an ATP dependent nucleosome remodeling factor. Nucleic Acids Res. 2001;29(12):2517-21, http://dx.doi.org/10.1093/nar/29.12.2517.
31. Targoff IN, Reichlin M. The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum. 1985;28(7):796-803, http://dx.doi. org/10.1002/art.1780280711.
32. Rutjes SA, Vree Egberts WTM, van Den Hoogen F, Pruijn GJM, van Vernrooij WJ. Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin Exp Immunol. 1997;109(1):32-40, http://dx.doi.org/10.1046/j.1365-2249.1997.4081308.x.
33. Ben-Chetrit E, Fox RI, Tan EM. Dissociation of immune responses to the SS-A/Ro 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjögren's syndrome. Arthritis Rheum 1990;33(3):349-55, http://dx. doi.org/10.1002/art.1780330307.
34. Isenberg D, Cambridge J, Maddison PJ. Prevalence of Ro (SS-A) antibodies in patients with polymyositis [abstract]. Arthritis Rheum 1987;30(11):1320, http://dx.doi.org/10.1002/art.1780301124.
35. Yamagata H, Akizuki M, Tojo T, Homma M. Anti-Ro/SSA and-La/SSB antibodies in patients with connective tissue diseases. Scand J Rheumatol Suppl. 1986;61:98-101.
36. Kubo M, Ihn H, Asano Y, Yamane K, Yazawa N, Tamaki K. Prevalence of 52-kd and 60-kd Ro/SS-A autoantibodies in Japanese patients with polymyositis/dermatomyositis. J Am Acad Dermatol. 2002;47(1):148-51, http://dx.doi.org/10.1067/mjd.2002.121037.
37. La Corte R, Lo Mo Naco A, Locaputo A, Dolzani F, Trotta F. In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease. Autoimmunity. 2006;39(3):249-53, http://dx.doi.org/10.1080/08916930600623791.
38. Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF, et al. Short-term and long-term outcome of anti-jo1-positive patients with anti-Ro52 antibody. Semin Arthritis Rheum. 2012;41(6):890-9, http://dx.doi. org/10.1016/j.semarthrit.2011.09.008.
39. Targoff IN, Mamyrova G, Trieu EP, Perurena O, Koneru B, O'Hanlon TP, et al. Childhood Myositis Heterogeneity Study Group; International Myositis Collaborative Study Group. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum. 2006;54(11):3682-9, http://dx.doi.org/10.1002/art.22164.
40. Matsushita T, Hasegawa M, Fujimoto M, Hamaguchi Y, Komura K, Hirano T, et al. Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis. J Rheumatol. 2007;34(5):1012-8.